Today's Rundown Featured Story | | | Tuesday, April 21, 2020 Americans have been told daily—by politicians, by experts, by the media—that researchers are urgently working on COVID-19 vaccines, and that one might be available in 12 to 18 months. But one analyst says he doesn't see it happening. Here's why. |
|
|---|
|
Top Stories Tuesday, April 21, 2020 Michigan-based hospital system Beaumont Health became the latest major health system to shed workers due to the COVID-19 financial crisis. Tuesday, April 21, 2020 Big Pharma companies have the will to create experimental vaccines and treatments for COVID-19, but they also want more financial help from governments to help them push on. Tuesday, April 21, 2020 Congress has reached a major deal that includes $75 billion in funding for hospitals that have been struggling financially during the COVID-19 outbreak. Tuesday, April 21, 2020 Hydroxychloroquine, the medicine that gained early attention on praise from President Donald Trump and others, has failed a study in VA hospitals. Pharma’s reputation has benefited from the pandemic, and the FDA has signed off on a new at-home testing kit from LabCorp. Plus more headlines. Tuesday, April 21, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Tuesday, April 21, 2020 In recent months, people across many different fields have tried to take what they know and pivot it toward the challenges posed by the COVID-19 outbreak: some that you may expect—such as diagnostics, healthcare and tech companies, of course—and some you may not. Tuesday, April 21, 2020 When it comes to knowing how COVID-19 will shape the future of healthcare, HCA Healthcare doesn't claim to have any special insight into how it will play out. But that isn't stopping it from trying to make plans. Here's what executives had to say about how they're weathering COVID-19. Tuesday, April 21, 2020 The FDA has given the green light to its first at-home test for COVID-19, allowing people to collect nasal swab samples themselves and then ship them to a clinical laboratory to be analyzed for signs of the novel coronavirus. Tuesday, April 21, 2020 A group of major CRO, life science, data analytics, publishing and healthcare companies joined forces to release a pro bono research database to build up and integrate a central hub on the latest data out for COVID-19. Tuesday, April 21, 2020 Cigna and New York Life are partnering to provide financial support to the families of healthcare workers who died fighting COVID-19. Tuesday, April 21, 2020 After a series of high-profile failures, compounding pharmacies took their share of body blows from an FDA looking to impose its will. Now, after years of lockdown, the FDA is turning to those very pharmacies to help ease the supply woes COVID-19 has inflicted on hard-hit hospitals. Tuesday, April 21, 2020 Consumers' impression of pharma companies has soared during the COVID-19 pandemic, with 40% now reporting that they have a more positive view of the industry than they did before the pandemic began, according to recent data from The Harris Poll. |
|
